| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.44 | 0.0003 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |